世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米の大動脈弁置換装置市場の2030年までの予測 製品別(無縫合弁、機械式弁)、手術別(低侵襲手術、開腹手術)、エンドユーザー別(病院&クリニック、外来手術センター、その他)の地域別分析


North America Aortic Valve Replacement Devices Market Forecast to 2030 Regional Analysis by Product (Sutureless Valve and Mechanical Valve), Surgery (Minimally Invasive Surgery and Open Surgery), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others).

北米の大動脈弁置換装置市場は、2022年の33億3,333万米ドルから2030年には86億3,328万米ドルに成長すると予測されている。2022年から2030年までの年平均成長率は12.6%と推定される。 大動脈弁置換手術件数の増... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2024年1月24日 US$3,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
86 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

北米の大動脈弁置換装置市場は、2022年の33億3,333万米ドルから2030年には86億3,328万米ドルに成長すると予測されている。2022年から2030年までの年平均成長率は12.6%と推定される。

大動脈弁置換手術件数の増加が北米の大動脈弁置換デバイス市場を後押し

最近、世界中で大動脈弁置換手術の件数が大幅に増加している。The Texas Herat Instituteが発表したデータによると、米国では年間〜106,000件の心臓弁手術が行われている。僧帽弁または大動脈弁は、これらの手術のほとんどすべてにおいて修復または置換されている。この急増は、医療技術の進歩、人口の高齢化、心臓関連の疾患に対する意識の向上など、いくつかの要因に起因している。大動脈弁置換術は、大動脈弁狭窄症や逆流症の治療にしばしば用いられる重要な手技である。医学が進化し続けるにつれて、これらの手術はより安全で利用しやすくなり、大動脈弁疾患に罹患した患者の予後改善と生活の質の向上に貢献すると期待されている。医療システムは、外科的介入に対するこのような需要の高まりに対応するために適応しており、心血管系の健康管理における予防措置と早期発見の重要性を強調している。

北米の大動脈弁置換装置市場概要

北米の大動脈弁置換装置市場は、米国、カナダ、メキシコに区分される。同地域の市場成長は、心臓疾患の有病率の上昇、規制当局の承認、研究開発活動、新製品発売の増加に起因している。さらに、多数の心臓センター、専門医療センター、外来手術センター、有利な償還シナリオが、2022-2030年の北米における大動脈弁置換装置市場の成長を後押しすると予想されている。

北米の大動脈弁置換装置市場の売上高と2030年までの予測 (百万米ドル)

北米の大動脈弁置換装置市場のセグメンテーション

北米の大動脈弁置換装置市場は、製品、手術、エンドユーザー、国別にセグメント化されています。

製品別では、北米の大動脈弁置換装置市場は無縫合弁と機械式弁にセグメント化される。2022年の北米大動脈弁置換装置市場は無縫合弁が大きなシェアを占めている。

手術に基づくと、北米の大動脈弁置換装置市場は低侵襲手術と開腹手術に区分される。低侵襲手術セグメントは、2022年に北米の大動脈弁置換装置市場でより大きなシェアを占めた。

エンドユーザーに基づくと、北米の大動脈弁置換装置市場は病院&クリニック、外来手術センター、その他に区分される。病院&診療所セグメントは、2022年に北米で最大の大動脈弁置換装置市場シェアを占めた。

国別では、北米の大動脈弁置換装置市場は、米国、カナダ、メキシコに分類されている。2022年の北米大動脈弁置換装置市場は米国が支配的であった。

Abbott Laboratories; Artivion Inc; Boston Scientific Corp; Braile Biomedica Industry, Commerce and Representations Ltd; Edwards Lifesciences Corp; LivaNova Plc; Medtronic Plc; JenaValve Technology Inc; and Venus MedTech HangZhou Inc;は、北米の大動脈弁置換装置市場で事業を展開している大手企業である。

ページTOPに戻る


目次

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Aortic Valve Replacement Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. North America Aortic Valve Replacement Devices Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Number of Aortic Valve Replacement Surgeries
5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:
6. Aortic Valve Replacement Devices Market - North America Market Analysis
6.1 North America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
7. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
7.3.1 Overview
7.3.2 Mechanical Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
7.4.1 Overview
7.4.2 Sutureless Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Surgery.
8.1 Overview
8.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
8.3.1 Overview
8.3.2 Open Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
8.4.1 Overview
8.4.2 Minimally Invasive Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by End User.
9.1 Overview
9.2 North America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers : North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Aortic Valve Replacement Devices Market – Country Analysis
10.1 North America: Aortic Valve Replacement Devices Market
10.1.1 Overview
10.1.2 North America: North America Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
10.1.2.1 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.1.4 US: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.1.5 US: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.2.4 Canada: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.2.5 Canada: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
11. North America Aortic Valve Replacement Devices Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Artivion Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 JenaValve Technology Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Venus MedTech HangZhou Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

 

ページTOPに戻る


 

Summary

The North America aortic valve replacement devices market is expected to grow from US$ 3,333.33 million in 2022 to US$ 8,603.28 million by 2030. It is estimated to grow at a CAGR of 12.6% from 2022 to 2030.

Rising Number of Aortic Valve Replacement Surgeries Fuels North America Aortic Valve Replacement Devices Market

There has been a significant increase in the number of aortic valve replacement surgeries performed worldwide recently. According to data published by The Texas Herat Institute, ~106,000 heart valve procedures are performed annually in the US. The mitral or aortic valves are repaired or replaced in almost all of these procedures. This surge can be attributed to several factors, including advancements in medical technology, an aging population, and improved awareness of heart-related conditions. Aortic valve replacement is a critical procedure often used to treat aortic valve stenosis or regurgitation, conditions that can lead to serious complications if left untreated. As medical science continues to evolve, these surgeries are expected to become even safer and more accessible, contributing to better patient outcomes and improved quality of life for those affected by aortic valve diseases. Healthcare systems are adapting to accommodate this growing demand for surgical interventions, emphasizing the importance of preventive measures and early detection in managing cardiovascular health.

North America Aortic Valve Replacement Devices Market Overview

The North America aortic valve replacement devices market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the rising prevalence of heart diseases and increasing number of regulatory approvals, R&D activities, and new product launches. Additionally, a large number of cardiac centers, specialty care centers, and ambulatory surgical centers, as well as favorable reimbursement scenarios, are expected to boost the aortic valve replacement devices market growth in North America during 2022–2030.

North America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Aortic Valve Replacement Devices Market Segmentation

The North America aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the North America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger North America aortic valve replacement devices market share in 2022.

Based on surgery, the North America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger North America aortic valve replacement devices market share in 2022.

Based on end user, the North America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest North America aortic valve replacement devices market share in 2022.

Based on country, the North America aortic valve replacement devices market has been categorized into the US, Canada, and Mexico. The US dominated the North America aortic valve replacement devices market in 2022.

Abbott Laboratories; Artivion Inc; Boston Scientific Corp; Braile Biomedica Industry, Commerce and Representations Ltd; Edwards Lifesciences Corp; LivaNova Plc; Medtronic Plc; JenaValve Technology Inc; and Venus MedTech HangZhou Inc; are some of the leading companies operating in the North America aortic valve replacement devices market.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Aortic Valve Replacement Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. North America Aortic Valve Replacement Devices Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Number of Aortic Valve Replacement Surgeries
5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:
6. Aortic Valve Replacement Devices Market - North America Market Analysis
6.1 North America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
7. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
7.3.1 Overview
7.3.2 Mechanical Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
7.4.1 Overview
7.4.2 Sutureless Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Surgery.
8.1 Overview
8.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
8.3.1 Overview
8.3.2 Open Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
8.4.1 Overview
8.4.2 Minimally Invasive Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by End User.
9.1 Overview
9.2 North America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers : North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Aortic Valve Replacement Devices Market – Country Analysis
10.1 North America: Aortic Valve Replacement Devices Market
10.1.1 Overview
10.1.2 North America: North America Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
10.1.2.1 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.1.4 US: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.1.5 US: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.2.4 Canada: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.2.5 Canada: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
11. North America Aortic Valve Replacement Devices Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Artivion Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 JenaValve Technology Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Venus MedTech HangZhou Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る